Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective

被引：0
|
作者：
Barbara Fischer
Andreas Serra
Harry Telser
机构：
[1] Polynomics,Department of Internal Medicine and Nephrology
[2] Klinik Hirslanden,Center for Health, Policy and Economics
[3] University of Lucerne,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Chronic kidney disease; Hyperkalemia; Patiromer; Potassium binder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2717 / 2730
页数：13
相关论文
共 37 条
  • [1] Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin-Angiotensin-Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective
    Fischer, Barbara
    Serra, Andreas
    Telser, Harry
    ADVANCES IN THERAPY, 2022, 39 (06) : 2717 - 2730
  • [2] Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden
    Widen, Julia
    Ivarsson, Magnus
    Schalin, Lovisa
    Vrouchou, Polina
    Schwenkglenks, Matthias
    Heimburger, Olof
    Ademi, Zanfina
    Sutherland, C. Simone
    PHARMACOECONOMICS, 2020, 38 (07) : 747 - 764
  • [3] Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors
    Weir, Matthew R.
    Bakris, George L.
    Gross, Coleman
    Mayo, Martha R.
    Garza, Dahlia
    Stasiv, Yuri
    Yuan, Jinwei
    Berman, Lance
    Williams, Gordon H.
    KIDNEY INTERNATIONAL, 2016, 90 (03) : 696 - 704
  • [4] Management of Hyperkalemia in Patients with Chronic Kidney Disease Using Renin Angiotensin Aldosterone System Inhibitors
    Fravel, Michelle A.
    Meaney, Calvin J.
    Noureddine, Lama
    CURRENT HYPERTENSION REPORTS, 2023, 25 (11) : 395 - 404
  • [5] A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
    Ramon Gonzalez-Juanatey, Jose
    Gonzalez-Franco, Alvaro
    de Sequera, Patricia
    Valls, Marta
    Ramirez de Arellano, Antonio
    Pomares, Elisenda
    Nieves, Diana
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 640 - 649
  • [6] Management of Hyperkalemia in Patients with Chronic Kidney Disease Using Renin Angiotensin Aldosterone System Inhibitors
    Michelle A. Fravel
    Calvin J. Meaney
    Lama Noureddine
    Current Hypertension Reports, 2023, 25 : 395 - 404
  • [7] Management of Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor: Strategies to Maintain Chronic Kidney Disease Patients with Type II Diabetes on Therapy
    Mahmud, Humaira A.
    Palmer, Biff F.
    CARDIORENAL MEDICINE, 2024, 14 (01) : 191 - 201
  • [8] Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis
    Palmer, Biff F.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (02) : 339 - 354
  • [9] Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial
    Weir, Matthew R.
    Rossignol, Patrick
    Pitt, Bertram
    Lund, Lars H.
    Coats, Andrew J. S.
    Filippatos, Gerasimos
    Perrin, Amandine
    Waechter, Sandra
    Budden, Jeffrey
    Kosiborod, Mikhail
    Metra, Marco
    Boehm, Michael
    Ezekowitz, Justin A.
    Bayes-Genis, Antoni
    Mentz, Robert J.
    Ponikowski, Piotr
    Senni, Michele
    Castro-Montes, Eliodoro
    Nicolau, Jose Carlos
    Parkhomenko, Alexandr
    Seferovic, Petar
    Cohen-Solal, Alain
    Anker, Stefan D.
    Butler, Javed
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (06) : 672 - 689
  • [10] Hyperkalemia: A Cause of Non-adherence to Renin-Angiotensin-Aldosterone System Inhibitors in Chronic Kidney Disease: A Retrospective Study
    Gulcicek, Sibel
    Seyahi, Nurhan
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (04): : 404 - 411
1234